DarioHealth Corp. Announces Board Changes and Executive Compensation Updates
Ticker: DRIO · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-changes
Related Tickers: DRIO
TL;DR
DarioHealth Corp. (DRIO) filed an 8-K detailing board changes and exec comp. Watch for leadership shifts.
AI Summary
DarioHealth Corp. announced on February 24, 2025, a change in its board of directors, including the departure of certain officers and the election of new directors. The company also reported on compensatory arrangements for its officers and filed financial statements and exhibits. This 8-K filing details significant corporate governance and executive compensation updates for DarioHealth Corp.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, leadership stability, and future financial performance.
Risk Assessment
Risk Level: medium — Board and executive changes can indicate internal shifts that may impact future performance and strategy.
Key Players & Entities
- DarioHealth Corp. (company) — Registrant
- February 24, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of incorporation
- 001-37704 (filing_id) — Commission File Number
- 45-2973162 (tax_id) — IRS Employer Identification No.
- 322 W. 57th St , #33B New York , New York 10019 (address) — Principal Executive Offices
FAQ
What specific changes were made to DarioHealth Corp.'s board of directors?
The filing indicates the departure of certain officers and the election of new directors, though specific names are not detailed in the provided text.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is February 24, 2025.
What are the primary items covered in this Form 8-K filing?
The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, other events, and financial statements and exhibits.
What is the principal executive office address for DarioHealth Corp.?
The principal executive office address is 322 W. 57th St , #33B New York , New York 10019.
What was DarioHealth Corp.'s former company name?
DarioHealth Corp.'s former company name was LabStyle Innovations Corp.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding DarioHealth Corp. (DRIO).